Shares of Teleflex Incorporated (NYSE:TFX – Get Free Report) have earned a consensus recommendation of “Hold” from the eight ratings firms that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $140.8333.
TFX has been the topic of a number of recent analyst reports. Truist Financial raised their target price on shares of Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research note on Thursday, December 18th. Needham & Company LLC boosted their price target on shares of Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Wall Street Zen lowered shares of Teleflex from a “hold” rating to a “sell” rating in a report on Saturday, March 7th. Weiss Ratings restated a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Finally, Wells Fargo & Company lifted their price objective on shares of Teleflex from $116.00 to $130.00 and gave the stock an “equal weight” rating in a report on Friday, February 27th.
Get Our Latest Stock Report on Teleflex
Hedge Funds Weigh In On Teleflex
Teleflex Price Performance
Shares of NYSE TFX opened at $106.57 on Friday. The firm has a market capitalization of $4.71 billion, a P/E ratio of -5.19, a P/E/G ratio of 0.66 and a beta of 0.87. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81. The stock’s 50-day simple moving average is $108.58 and its two-hundred day simple moving average is $116.96. Teleflex has a twelve month low of $100.18 and a twelve month high of $142.96.
Teleflex (NYSE:TFX – Get Free Report) last released its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share for the quarter, missing the consensus estimate of $3.73 by ($1.80). Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The business had revenue of $569.00 million during the quarter, compared to analysts’ expectations of $912.57 million. During the same period in the previous year, the business earned $3.89 EPS. The business’s revenue was down 28.5% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities analysts anticipate that Teleflex will post 13.98 EPS for the current fiscal year.
Teleflex Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 6th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a yield of 1.3%. Teleflex’s dividend payout ratio (DPR) is presently -6.62%.
About Teleflex
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Featured Stories
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
